Refine by
Medical Product Articles & Analysis: Older
406 news found
Many medical devices are manufactured through plastic injection moulding, which allows for precise and top-quality components in large-scale production and better aligns with ISO standards. ...
U.S. medical device regulations require manufacturers of most class II and a small number of class I devices to file a 510(k) unless they qualify for an exemption. 510(k) is a premarket technical document submitted by the manufacturer to the FDA before the medical device product enters the US market to prove that the product has ...
As a global company dedicated to innovation in medical devices, we recognized that representation matters—not just in our workforce, but in the way we present our products. During the production of our IV Catheter video animation, we worked with the animators to showcase a diverse range of skin tones. ...
Medical device testing is a crucial step in the development and commercialization of innovative medical devices. ...
BySTEMart
MedSource Labs understands the critical importance of ensuring clinician access to high-quality medical supplies, as it directly impacts patient care and outcomes. In the face of global challenges, such as supply chain disruptions due to a spike in geopolitical conflicts, the time it takes to move products by sea and air has vastly increased. ...
Their support is instrumental to making this improved access a reality,” said Philippe Menu, M.D., Ph.D, Chief Medical and Chief Product Officer, SOPHiA GENETICS. “Additionally, the breadth and depth of real-world data that we will generate through the implementation of this decentralized liquid biopsy testing platform on a global scale will be ...
We are very excited at the prospect of contributing to meaningful clinical advances for patients with ecDNA-driven oncogene amplified cancers,” said Philippe Menu, M.D., PhD., Chief Medical Officer and Chief Product Officer, SOPHiA GENETICS. SOPHiA GENETICS provides a technology-agnostic cloud-native platform for the computing, standardization and analysis ...
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. ...
MedSource Labs Moves the Needle in the Peripheral Safety IV Market With the announcement of ClearSafe Comfort® and TrueSafe Comfort® Blood Control IV Catheters with groundbreaking active check valve ...
These services are designed to help medical device manufacturers meet regulatory requirements and ensure the safety and effectiveness of their products. Medical device safety testing is a critical component of the product development process, ensuring that medical devices meet regulatory requirements and are safe ...
In a ground-breaking advancement for cardiovascular care, Hiden Analytical Ltd is proud to announce a surface measurement technique for devices critical in the treatment of heart disease. Utilizing the most sensitive surface analysis technology, Secondary Ion Mass Spectrometry (SIMS), Hiden Analytical is setting new standards in the safety, efficacy, and innovation of stent technology. Surgical ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, is proud to announce the launch of its new Pilot Production Services for the medical device industry. ...
BySTEMart
Semaglutide Side Chain serves as a pivotal component in the synthesis of semaglutide, an innovative medication utilized in the treatment of type 2 diabetes. Huateng Pharma's unwavering dedication to excellence and innovation shines through in the meticulous development and production of these essential compounds, ensuring the highest standards of quality and ...
In addition, it elucidates trends in electronics, medical, automotive, and consumer product industries, exploring components, devices, key market players, regulatory standards, and environmental considerations. ...
This offering presents unparalleled opportunity for data enrichment and insight for medical device industry partners. “The ability to capture and deliver data insights across the entire cycle of care presents a new avenue for partners to measure value and improve outcomes with a data-first approach. ...
After a procedure, the Caresyntax platform provides insights that help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. ...
After a procedure, the Caresyntax platform provides insights that help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. ...
Food and Drug Administration (“FDA”) has announced a new medical device product classification “whole room microbial reduction device” which establishes FDA regulation of UV robots intended to reduce the number of pathogens in unoccupied patient rooms, operating rooms and other areas in healthcare facilities where non-critical ...
These innovative technologies offer targeted and sustained release of therapeutic agents, promoting improved patient compliance and efficacy. However, as with any medical product, it is crucial to assess the safety and potential toxicity of these novel drug delivery platforms. ...
We believe we can provide a safer alternative to other THC products providing the benefits without the negative psychiatric side effects. ...